4//SEC Filing
RXi Pharmaceuticals Corp 4
Accession 0001209191-17-028260
$PHIOCIK 0001533040operating
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 6:36 PM ET
Size
5.3 KB
Accession
0001209191-17-028260
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Stock option (right to buy)
2017-04-24+95,000→ 95,000 totalExercise: $0.65Exp: 2027-04-24→ Common stock (95,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001533040
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 6:36 PM ET
- Size
- 5.3 KB